Neogene licenses portfolio of TCRs targeting KRAS and TP53 mutations from NCI Jan. 12, 2022 No Comments
Dren Bio and Pfizer collaborate to discover and develop bispecific antibodies for cancer Jan. 12, 2022 No Comments
BioNTech and Crescendo Biologics partner to develop immunotherapies for cancer and other diseases Jan. 11, 2022 No Comments
HotSpot and Caris enter strategic partnership to advance HotSpot's portfolio Jan. 11, 2022 No Comments
Carisma and Moderna collaborate to generate and develop in vivo CAR-M therapeutics Jan. 11, 2022 No Comments
Century and Bristol Myers Squibb collaborate to develop iPSC-derived allogeneic cell therapies Jan. 11, 2022 No Comments
Cullinan collaborates with Mount Sinai to develop HPK1 protein degraders for cancer Jan. 10, 2022 No Comments
Series A financing at ONK Therapeutics to support NK cell therapies through IND-enabling studies Jan. 7, 2022 No Comments
RSS